Log in to search using one of your social media accounts:

 

Novel therapeutic target discovered for estrogen receptor positive (ER+) breast cancer
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Mount Sinai researchers identify new protein in a common subtype of breast cancer which can potentially offer more effective therapies for the future. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 17, 2017 Category: Cancer & Oncology Source Type: news

NICE gives green light to new 'breakthrough' breast cancer drugs
Discount price deals for two similar new breast cancer drugs have seen them approved for routine NHS use, under draft guidance from the National Institute for Health and Care Excellence. (Source: Nursing Times)
Source: Nursing Times - November 16, 2017 Category: Nursing Source Type: news

How a Tiny Breast Cancer Device Carries Big Value
With all the uncertainty in today's healthcare system, the one thing everyone seems to agree on is that value-based care is here to stay. Cianna Medical understands that particularly well, and the company's latest FDA clearance is expected to add even more value to the continuum of care for breast cancer patients and their providers. Cianna's Savi Scout reflector can now be implanted in breast cancer patients without restrictions on the length of time that it can remain in the breast. The device is a non-radioactive implant used in wire-free localization. It is only activated when a special handpiece, which acts as the rad...
Source: MDDI - November 16, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Implants Source Type: news

Thousands to benefit as 'breakthrough' breast cancer drugs approved for NHS use
Annually, 8,000 women in England with previously untreatable advanced breast cancer will have access to drugs shown to slow disease ’s progressionThousands of women with previously untreatable breast cancer will have access to two “breakthrough” drugs that have been approved for NHS use.The drugs, called palbociclib and ribociclib, have been shown to slow the progression of advanced cancer by at least 10 months and can delay the need for chemotherapy, giving women the chance to live a normal life for longer. In new draft guidance, the National Institute for Health and Care Excellence (Nice) has approved t...
Source: Guardian Unlimited Science - November 16, 2017 Category: Science Authors: Hannah Devlin Tags: Breast cancer Health Society Science The National Institute for Health and Care Excellence (Nice) NHS Drugs Source Type: news

'Breakthrough' breast cancer drugs get NHS approval
Research shows the two new treatments can slow the cancer down and delay the need for chemotherapy. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 16, 2017 Category: Consumer Health News Source Type: news

Up to 8,000 women to benefit from new cancer drug
The drugs are hailed as the ‘closest thing to a cure’ for women with incurable breast cancer. Vikki Orvice (pictured), from St Albans, has been able to work full-time thanks to the wonder drugs. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2017 Category: Consumer Health News Source Type: news

Pfizer, Novartis agree UK price cuts for new breast cancer drugs
LONDON (Reuters) - Pfizer and Novartis have agreed price cuts for their rival breast cancer drugs Ibrance and Kisqali to ensure they can be used routinely within Britain's state-funded health service. (Source: Reuters: Health)
Source: Reuters: Health - November 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
Ammonia is a ubiquitous by-product of cellular metabolism; however, the biological consequences of ammonia production are not fully understood, especially in cancer. We found that ammonia is not merely a toxic waste product but is recycled into central amino acid metabolism to maximize nitrogen utilization. In our experiments, human breast cancer cells primarily assimilated ammonia through reductive amination catalyzed by glutamate dehydrogenase (GDH); secondary reactions enabled other amino acids, such as proline and aspartate, to directly acquire this nitrogen. Metabolic recycling of ammonia accelerated proliferation of ...
Source: ScienceNOW - November 16, 2017 Category: Science Authors: Spinelli, J. B., Yoon, H., Ringel, A. E., Jeanfavre, S., Clish, C. B., Haigis, M. C. Tags: Biochemistry, Medicine, Diseases reports Source Type: news

NICE approves breakthrough breast cancer drugs
New class of cancer treatment drugs approved for NHS Related items fromOnMedica The genetics of breast cancer Ovarian cancer drug may help stall breast cancer Experts recommend anastrozole for postmenopausal women with family history of breast cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 16, 2017 Category: UK Health Source Type: news

NAFLD Linked to Higher Incidence Rates of Cancer (CME/CE)
(MedPage Today) -- Significantly associated with HCC, colon cancer in men, and breast cancer in women (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 15, 2017 Category: Gastroenterology Source Type: news

Diabetes May Be Driving High Rates of Breast Cancer in Black Women
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 15, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Diabetes, Preventive Medicine, News, Source Type: news

Diabetes Driving Breast Cancer Up in Black Women?
Type 2 diabetes may increase the risk for an aggressive type of breast cancer among black women in the United States, a new study finds. (Source: WebMD Health)
Source: WebMD Health - November 15, 2017 Category: Consumer Health News Source Type: news

Diabetes May Be Driving High Rates of Breast Cancer in Black Women
WEDNESDAY, Nov. 15, 2017 -- Type 2 diabetes may increase the risk for an aggressive type of breast cancer among black women in the United States, a new study finds. Researchers from Boston University analyzed data from more than 54,000 black women... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 15, 2017 Category: General Medicine Source Type: news

Diabetes May Be Driving High Rates of Breast Cancer in Black Women
Title: Diabetes May Be Driving High Rates of Breast Cancer in Black WomenCategory: Health NewsCreated: 11/15/2017 12:00:00 AMLast Editorial Review: 11/15/2017 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - November 15, 2017 Category: Endocrinology Source Type: news

Oncotarget: Researchers identify potential therapeutic target in aggressive breast cancer cells
(Rapamycin Press) An especially aggressive breast cancer cell can respond to hormone therapy if they express a specific protein known as estrogen receptor beta, according to research published in Oncotarget. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Type 2 diabetes associated with risk of aggressive breast cancer in black women
(Boston University School of Medicine) African American women with type 2 diabetes (often referred to as adult-onset diabetes) are at a greater risk for developing breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

African-American women with type 2 diabetes may have higher risk for ER-neg breast cancer
(American Association for Cancer Research) Among African-American women, those with type 2 diabetes may have a higher risk of developing estrogen receptor (ER)-negative breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Faslodex (fulvestrant) Receives FDA Approval for the Treatment of Advanced Breast Cancer in Combination with Abemaciclib
15 November 2017 -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved a new indication for Faslodex (fulvestrant), expanding the indication to include use with abemaciclib, a CDK4/6 inhibitor, for the treatment... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 15, 2017 Category: Drugs & Pharmacology Source Type: news

Diabetes May Be Driving High Rates of Breast Cancer in Black Women
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Low vitamin D linked to poorer fertility treatment outcomes
Time for clinical trial to see if supplements could boost live birth rate, say researchers Related items fromOnMedica Fertility treatments may impact on breast cancer risk Infertility Vitamin D deficiency increases risk of chronic headache Vitamin D supplements may cut risk of acute respiratory infections Vitamin D (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 15, 2017 Category: UK Health Source Type: news

Jax company starts trial on cancer-fighting therapy
Jacksonville-based TapImmune Inc. (Nasdaq: TPIV) has enrolled its final patient in a randomized, Phase 2 clinical study of an immunotherapy that targets breast cancer. TapImmune's therapies help the body's immune system find and fight cancer, which has evolved to hide from and suppress it, CEO Peter Hoang previously told the Business Journal. This approach is outside of the box of traditional treatment methods like surgery, chemotherapy and radiation therapy tha t shut-down pathways for cancer to… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 14, 2017 Category: American Health Authors: Will Robinson Source Type: news

SPM Conference
Discussions noted and collected will serve as the basis of a number of internal advocacy efforts. Let’s keep the conversation going on Connect! Our inaugural meeting was certified as Patients Included, a designation given to an event that meets all 5 of the Patients Included charter: Missed the event and couldn’t catch the live-stream? Loved the meeting so much you wish you could experience it all over again? We’ve got you covered! Here are speakers’ presentations from the inaugural Society for Participatory Medicine conference. Looking forward to our second annual meeting in 2018! Stay tuned for d...
Source: Society for Participatory Medicine - November 13, 2017 Category: General Medicine Authors: Nanette Mattox Tags: Newsletter Source Type: news

Nearly 1 in 3 Breast Cancer Pts Skip Adjuvant Therapy: Why? Nearly 1 in 3 Breast Cancer Pts Skip Adjuvant Therapy: Why?
A general distrust in the healthcare system, but not their personal physician, leads nearly 1 in 3 women with early breast cancer to opt out of or fail to complete adjuvant therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

FDA clears Cianna Medical ’ s Savi Scout breast cancer locator for long term implants
Cianna Medical said today that the Savi Scout reflector, part of its system for wire-free breast tumor localization, won FDA clearance as the first non-radioactive implant without a restriction on the length of time that the reflector can remain in a patient’s breast. The new clearance means that doctors can place Scout to mark a biopsy or lumpectomy site and not be constrained by a maximum implant time, the Aliso Viejo, Calif.-based company said. The Scout reflector also won’t interfere with MRI studies, so doctors aren’t restricted in the types of imaging modalities they can use with their patients. The...
Source: Mass Device - November 13, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Oncology Regulatory/Compliance Women's Health Cianna Medical Source Type: news

Researchers Build a Cancer Immunotherapy Without Immune Cells
A team has engineered two stem cell lines into 'synthetic T cells' that destroy breast cancer cells in vitro. (Source: The Scientist)
Source: The Scientist - November 13, 2017 Category: Science Tags: Daily News Source Type: news

Top Healthcare Trends Affecting Cancer Business in 2017 Impact Pathologists and Medical Laboratory Leaders Who Serve Oncologists and Patients
Many aspects of traditional clinical laboratory pathology testing remain rooted to cancer care even as the cancer care industry embraces precision medicine, and digital pathology testing and interpretation There’s good news for anatomic pathologists worried about the future of the pathology profession. A recent survey of oncology program participants in the United States determined that […] (Source: Dark Daily)
Source: Dark Daily - November 13, 2017 Category: Laboratory Medicine Authors: Jude Tags: Laboratory Management and Operations Laboratory Operations Laboratory Pathology Laboratory Testing Management & Operations ACCC Advisory Board Anthem Association of Community Cancer Care Centers Breast Cancer Ally Cancer Care Quality P Source Type: news

Emerging Therapeutic Strategies in Breast Cancer Emerging Therapeutic Strategies in Breast Cancer
Breast cancer treatment is undergoing a rapid evolution with recent advances in genomics, tumor biology, and immunology. Learn how this translates into new therapeutics in this review.Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Nonalcoholic fatty liver disease increases risk of liver, colorectal, and breast cancers
(Elsevier) Nonalcoholic fatty liver disease (NAFLD) is one of the more common chronic liver diseases worldwide. It is associated with metabolic syndrome (i.e. insulin resistance and diabetes) and predisposes to cardiovascular disease. In a new study published in the Journal of Hepatology, researchers identified links not only between NAFLD and hepatocellular carcinoma (HCC), which have been well established, but also to cancers outside the liver, including colorectal and breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2017 Category: Cancer & Oncology Source Type: news

Epigenetic editing reveals surprising insights into early breast cancer development
(Queen Mary University of London) Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to begin a chain reaction and become abnormal, according to research by Queen Mary University of London (QMUL). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2017 Category: International Medicine & Public Health Source Type: news

FDA Cancer Drug Approvals in 2017
This slide show highlights some of this year ’s FDA approvals of cancer treatments, including new therapies and indications for breast cancer, lung cancer, and various blood cancers, as well as the first approval based not on disease site but by tumor marker. (Source: CancerNetwork)
Source: CancerNetwork - November 11, 2017 Category: Cancer & Oncology Authors: Cancer Network Editors Source Type: news

Cancer Carepoint brings no-cost care to Silicon Valley
Editor's note: Each year, the Silicon Valley Business Journal honors area groups and individuals who have made a significant difference in our community. Cancer Carepoint is one of our three Community Impact honorees this year. For Ann Marie Bongiorno, asking for help is not easy. But in the past few years, she’s learned it is lifesaving. In 2012, Bongiorno was diagnosed with Stage 3 breast cancer, and she quickly realized she was not alone, and could ask for help. That’s when she discovered… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 11, 2017 Category: Biotechnology Authors: Kevin Burbach Source Type: news

Cancer Carepoint brings no-cost care to Silicon Valley
Editor's note: Each year, the Silicon Valley Business Journal honors area groups and individuals who have made a significant difference in our community. Cancer Carepoint is one of our three Community Impact honorees this year. For Ann Marie Bongiorno, asking for help is not easy. But in the past few years, she’s learned it is lifesaving. In 2012, Bongiorno was diagnosed with Stage 3 breast cancer, and she quickly realized she was not alone, and could ask for help. That’s when she discovered… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 11, 2017 Category: Pharmaceuticals Authors: Kevin Burbach Source Type: news

Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
First Avastin® (Bevacizumab) Biosimilar Candidate Recommended for European Approval THOUSAND OAKS, Calif., Nov. 10, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc. (NYSE:AGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing Authorization of ABP 215, a biosimilar to Avastin® (bevacizumab). ABP 215 has been recommended for approval for the treatment of certain types of cancer, including in combination with fluoropyrimidine-based chemotherapy for metastatic carcinoma of the colon or rec...
Source: Amgen News Release - November 10, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Risk of breast cancer recurring persists after end of hormone therapy
According to a study, published in theNew England Journal of Medicine, women successfully treated for breast cancer with hormone therapy still have an increased risk of it returning, even 15 years after hormone therapy ended.Newsweek  (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 10, 2017 Category: Endocrinology Source Type: news

The New Health Care: A Link Between Alcohol and Cancer? It ’ s Not Nearly as Scary as It Seems
An announcement from a cancer research group needs to be taken with a grain of salt, perhaps on the rim of a margarita glass. (Source: NYT Health)
Source: NYT Health - November 10, 2017 Category: Consumer Health News Authors: AARON E. CARROLL Tags: Cancer Alcoholic Beverages Breast Cancer Research Deaths (Fatalities) Source Type: news

Antioxidant-rich tea OMGTea could help beat cancer
EXCLUSIVE: Katherine Swift, 45, from Brighton, was inspired to set up OMGTea following the news that her mother Elizabeth had stage 3 breast cancer and was facing chemotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - November 10, 2017 Category: Consumer Health News Source Type: news

Breast Cancer in Children
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 10, 2017 Category: General Medicine Source Type: news

More than 1,300 women to get breakthrough cancer drug
The treatment – for the aggressive HER2+ form of the disease – extends life for women dying with breast cancer by an average 56 months, 16 months more than the next best treatment. (Source: the Mail online | Health)
Source: the Mail online | Health - November 10, 2017 Category: Consumer Health News Source Type: news

Breast Cancer Recurrences Steady After Therapy Cessation
Women with ER - positive BC who stop therapy after 5 years have steady recurrence rate up to 20 years (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 10, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Pharmacy, Radiology, Surgery, Journal, Source Type: news

Risk for breast cancer's return can linger for decades
A new, large study finds that women treated for early stage breast cancer still face a substantial risk of recurrence up to 20 years later (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 9, 2017 Category: Consumer Health News Source Type: news

ACR releases breast cancer screening criteria
The American College of Radiology's (ACR) expert panel on breast imaging has...Read more on AuntMinnie.comRelated Reading: ACR updates Appropriateness Criteria Women still value mammography's benefits over 'harms' Annual breast screening reduces deaths by almost 40% 2D synthesized DBT screening is ready for prime time How do women fare when breast cancer is detected on US? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 9, 2017 Category: Radiology Source Type: news

Breast Cancer's Return Risk Can Linger for Decades
Women treated for early stage breast cancer still face a substantial risk of recurrence up to 20 years later, a large, new study shows. (Source: WebMD Health)
Source: WebMD Health - November 9, 2017 Category: Consumer Health News Source Type: news

Breast cancer 'can return 15 years after treatment ends'
Extending treatment with hormone therapy could reduce the risk of it recurring. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 9, 2017 Category: Consumer Health News Source Type: news

Ghana:Tigo-Airtel Climax Breast Cancer Month With Lunch, Fundraising
[Business Day] The newly merged Airtel and Tigo telecommunication climaxed this years' Breast Cancer Awareness last month with a sea of Pink dress-codes in solidarity with Breast Cancer survivors. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 9, 2017 Category: African Health Source Type: news

Nigeria:DG Nimasa Tasks Nigerians On Early Detection Against Cancer
[This Day] The Director General of the Nigerian Maritime Administration and Safety Agency (NIMASA), Dr. Dakuku Peterside has urged Nigerians especially women to ensure frequent Breast Cancer screening stressing that early detection will make a lot of difference in tackling the scourge. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 9, 2017 Category: African Health Source Type: news

Medical News Today: Risk of breast cancer's return continues long after treatment ends
Researchers find that the risk of breast cancer recurrence stays high for decades after treatment. They ask whether therapy should continue for longer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 9, 2017 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Risk of Breast Cancer's Return Can Linger for Decades
Title: Risk of Breast Cancer's Return Can Linger for DecadesCategory: Health NewsCreated: 11/8/2017 12:00:00 AMLast Editorial Review: 11/9/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 9, 2017 Category: Cancer & Oncology Source Type: news

USPSTF to review osteoporosis screening
The U.S. Preventive Services Task Force (USPSTF) is seeking comment on a draft...Read more on AuntMinnie.comRelated Reading: USPSTF to take another look at AAA screening USPSTF discourages thyroid cancer screening USPSTF seeks comment on pancreatic cancer guidance USPSTF: Why do more black women die from breast cancer? Ex-USPSTF heads say guidelines shouldn't guide payments (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 9, 2017 Category: Radiology Source Type: news